ABSTRACT
Introduction
chromosomal anomalies form the major cause of birth defects and mental retardations. All pregnancies carry a baseline risk of 3 % to 4 % for major congenital anomalies so the etiology for birth defects include chromosomal, single gene or Mendelian disorders, multifactorial, teratogenic or environmental effects (1) . this frequency is much higher in the early stages of pregnancy, because serious malformations and genetic disorders usually lead to spontaneous abortion (7, 16) . With the advancement of prenatal diagnostic techniques, more fetal abnormalities can be detected. Because there are no effective treatments for fetal abnormalities, prenatal diagnosis is an important means for diagnosing abnormalities in the unborn child (20) .
the use and understanding of ultrasound sonographic markers and their screening relative risks is an important option in the care of pregnant women (18) . Ultrasonography (USG), since its discovery, has been the primary imaging method in diagnosing fetal anomalies. USG has been used since the 1950's. With the progression of technological improvements with time, imaging with real-time USG, color Doppler, power Doppler, three-and four-dimensional USG has taken its place in fetal evaluation (7, 16, 18) . three-dimensional ultrasound (3D) and four-dimensional ultrasound (4D) can be applied in assessing facial features, central nervous system abnormalities and skeletal defects (7, 16) .
Fetuses with an abnormal karyotype are the topic of interest in ultrasonography, because they are usually characterized by specific, minor or even major, multiple anomalies accepted as sonographic markers of chromosomopathies (6, 8, 9, 14, 17, 18) . Many ultrasonographic minor markers, called soft markers, have been identified as risk factors for chromosomal abnormalities. these ultrasonographic markers, namely nuchal fold thickening, echogenic cardiac focus, echogenic bowel, mild ventriculomegaly and nasal bone hypoplasia, are associated with increased risk of aneuploidy of varying magnitude. Identification of any of these findings requires further counseling and possible referral to a prenatal diagnostic center with the provision of an option of an invasive test for fetal karyotyping. other sonographic markers, such as choroid plexus cyst, renal pyelectasis, short femur and single umbilical artery are not known to be associated with a significant risk of chromosomal anomalies, particularly if present in isolation. Thus, amniocentesis is not indicated for these findings alone. however, the presence of any of these markers certainly calls for a careful search for other malformations or other risk factors for chromosomal or genetic abnormalities (14) .
this study investigated the fetal karyotype after detection of major defects or soft marker on USG and studied the role of various factors, such as maternal age, gestational age and the number of cases with the type of ultrasonic marker (single or multiple marker on fetal USG). 
GENETIC ANALYSIS IN PREGNANCY WITH FETAL PATHOLOGIC ULTRASOUND FINDINGS

Materials and Methods
A total of 191 women were referred to our laboratory, which is at the Department of Medical Biology and Genetics, Dicle University in the city of Diyarbakir, Southeast turkey, for karyotype analysis, from January 2007 to December 2011. Women were also referred to our laboratory for karyotype analysis confirmation of findings after detection of a soft marker or of major malformations at the routine antenatal USG. Sonographic examination and then amniocentesis (if necessary) were performed by obstetricians at the Department of Gynecology and obstetrics, Dicle University hospital in the city of Diyarbakir, Southeast turkey.
All samples were analyzed in the Medical Biology and Genetic Department laboratory at Dicle University for cytogenetic analyses. the laboratory provides a prenatal service to obstetrics-gynecology departments of different hospitals in Diyarbakir and its surrounding province in Southeast turkey. A detailed interview was done with all couples before amniocentesis, and all couples were counseled about the risk of chromosomal disease and the risks and benefits of karyotyping procedures. informed consent for genetic testing was obtained from all patients. the study was approved by the ethic committee of the Medical Faculty of Dicle University, Diyarbakir, turkey (Protocol no.: B.30.2.Dic.0.01.00.00/57). this study was carried out in accordance with the principles of the helsinki Declaration.
Prenatal amniocentesis was performed using a 22-gauge needle by the obstetrician. The first 1 mL of the amniotic fluid was discarded to avoid contamination with maternal tissues. Then samples of 15 mL to 20 mL of amniotic fluid were sent to our cytogenetic laboratory and were cultivated according 
Results and Discussion
the practice of prenatal diagnosis in chromosomal abnormalities has been in use for nearly half century, since Steele and Breg (15) showed that the chromosome constitution of a fetus could be determined by analysis of cultured cells from the amniotic fluid in 1966. Karyotype analysis has been the standard method for prenatal cytogenetic diagnosis since the 1970s (12) . Ultrasonographic examination of fetuses has become a part of routine antenatal management. Detection of fetal abnormalities (soft markers or major malformations) at the routine antenatal USG can give useful information about significant increase in fetal risk for genetic disease (6, 8, 17) . in our study, 191 second-trimester amniocentesis cases with sonographically detected markers for fetal chromosomal abnormalities were analyzed in the cytogenetics laboratory in our prenatal genetic center between 2007 and 2011. General sample characteristics of the women are reported in Table 1 . the largest age group was that of patients between 30 and 39 years of age (38.7 %, n = 74), followed by 20-29 years of age (37.2 %, n = 71), over 40 (13.1 %, n = 25), and 19 years or younger (11 %, n = 21). the most prevalent gestational ages at the time of amniocentesis were: 18 weeks (35.6 %), followed by 17 weeks (30.4 %), 16 weeks (20.9 %), 15 weeks or less (9.4%), and 19 weeks or more (3.7 %). the most prevalent type of sonographic fetal marker on USG was the single sonographic marker (79.6 %, n = 152), followed by multiple sonographic markers (20.4 %, n = 39).
Of the 191 amniotic fluid samples cultivated according to the standard protocol, 189 cases were successfully cultivated and 2 amniotic fluid samples were not. The success rate of culturing was 98.95 % (189/191). We had no false positive or false negative results in the study.
the fetal karyotype was abnormal in 24.6 % of the cases (47/191). other authors have variously reported the incidence of chromosomal abnormalities in pregnancies with ultrasonically diagnosed fetal anomalies to range from 10.81 % to 43 % (2, 7, 9, 21) .
One hundred and fifty-two (152/191) karyotyping procedures were done due to the finding of a single sonographic marker. Within this group, 17.1 % (26/152) of the karyotypes were abnormal. thirty-nine (39/191) karyotyping procedures were done due to the finding of a multiple sonographic marker. in this group, a much higher proportion, 53.8 % (21/39), of the karyotypes were abnormal. Table 2 shows abnormal chromosome karyotype in 26 cases with a sonographic fetal marker on USG. Table 3 shows abnormal chromosome karyotype in 21 cases with a multiple sonographic fetal marker on USG. Similarly, higher incidence of chromosomal abnormalities in fetuses with multiple malformations compared to those with a single defect on USG has been demonstrated in numerous studies (2, 14) .
Among the fetal abnormality cases observed during the ultrasound examination, there were 47 ones with abnormal karyotype (24.6 %). Among them, 13 cases were with trisomy 21; 5 cases with trisomy 18; 1 case with trisomy 13; 2 cases with triploidy (69); 7 cases with karyotype 45,X; 1 case with karyotype 47,XXY; and 18 cases with other abnormal chromosome structures. the number of cases with each type of fetal abnormality in the ultrasound examination and abnormal karyotype is shown in Table 2 and Table 3 .
Many reports have documented termination rates following diagnosis of different types of fetal abnormalities, the incidence of termination varying across conditions. in our study, there were 29 cases with abnormal karyotype in which the pregnancy was terminated. the overall termination rate was 61.7 % (29/47) in cases with a fetus affected by chromosomal abnormalities. the termination rate was 50 % (13/26) for fetuses with a single sonographic marker. the termination rate was 76.2 % (16/21) for fetuses with multiple sonographic markers. Table 2 and Table 3 show the details of terminated cases. other authors have shown that the termination rates are highest following a prenatal diagnosis of Down syndrome and lowest following diagnosis of Klinefelter syndrome (3, 4, 5, 10, 11, 13, 19) . our results are in concordance with prior findings of an increased rate of termination in the case of a more severe prognosis (e.g. autosomal trisomy) compared with that for abnormal karyotypes with a less severe prognosis (e.g. sex chromosome aneuploidy) (3, 4, 5, 10, 11, 13, 19) .
the decision-making process regarding the termination of pregnancy is difficult both for the parents and the physician. that is why, genetic counseling is very important in prenatal diagnosis.
Conclusions
Some obstetric ultrasound findings are considered normal variants but are noteworthy because they also increase the risk of underlying fetal aneuploidy. therefore, ultrasound examination is important in prenatal diagnosis. Pregnant women with abnormal fetal in ultrasound examination should be prompted to have amniocentesis done for fetal chromosome analysis. Genetic counseling should be given to families.
